Warfarin application research and analysis in patients with non-valvular atrial fibrillation
- Author:
Xiao-Ming DU
1
Author Information
- Publication Type:Journal Article
- Keywords: Atrial fibrillation; Chronic disease management; Clinical pharmacist; Investigation analysis; Pharmaceutical care; Warlarin
- From: Chinese Pharmaceutical Journal 2015;50(22):2000-2003
- CountryChina
- Language:Chinese
- Abstract: OBJECTIVE: To understand the application of warfarin hospitalized patients with non-valvular atrial fibrillation, summarize the clinical experience and provide reference for clinical medication, and explore the significance of clinical pharmaceutical care for warfarin. METHODS: The information of 726 cases with non-valvular atrial fibrillation hospitalized in the first cardiovascular ward from January 2012 to December 2013 were retrospectively collected and analyzed in the aspect of types of anticoagulant solution, warfarin dosage and INR monitoring. RESULTS: The anticoagulation solution commonly used in our patients with atrial fibrillation included dual antiplatelet therapy, aspirin antithrombotic therapy and warfarin anticoagulant therapy. 13.8% of the cases had initial INR of 2.0-3.0, and 43.4% of the cases attained INR target after dosage adjustment. CONCLUSION: At present the clinical application of warfarin still exists deficiencies. It is necessary to continue to raise people's awareness of warfarin and atrial fibrillation anticoagulant. Active clinical pharmaceutical care for warfarin is of great significance.
